Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials

por Marcath, Lauren A., Coe, Taylor D., Hoylman, Emily K., Redman, Bruce G., Hertz, Daniel L.
Publicado 2018

A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma

por Kudchadkar, Ragini, Ernst, Scott, Chmielowski, Bartosz, Redman, Bruce G, Steinberg, Joyce, Keating, Anne, Jie, Fei, Chen, Caroline, Gonzalez, Rene, Weber, Jeffrey
Publicado 2015

Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports

por Tan, Meng H., Iyengar, Ravi, Mizokami-Stout, Kara, Yentz, Sarah, MacEachern, Mark P., Shen, Li Yan, Redman, Bruce, Gianchandani, Roma
Publicado 2019

Concurrent whole brain radiotherapy and bortezomib for brain metastasis

por Lao, Christopher D, Friedman, Judah, Tsien, Christina I, Normolle, Daniel P, Chapman, Christopher, Cao, Yue, Lee, Oliver, Schipper, Matt, Van Poznak, Catherine, Hamstra, Daniel, Lawrence, Theodore, Hayman, James, Redman, Bruce G
Publicado 2013

Retrospective Analysis of the Safety and Efficacy of High-dose Interleukin-2 After Prior Tyrosine Kinase Inhibitor Therapy in Patients With Advanced Renal Cell Carcinoma

por Lam, Elaine T., Wong, Michael K. K., Agarwal, Neeraj, Redman, Bruce G., Logan, Theodore, Gao, Dexiang, Flaig, Thomas W., Lewis, Karl, Poust, Jamie, Monk, Paul, Jarkowski, Anthony, Sendilnathan, Arun, Bolden, Marcus, Kuzel, Timothy M., Olencki, Thomas
Publicado 2014